Drug safety and the safety of patients: The challenge to medicine and health from permissive expert risk assessments of triazolam (Halcion)

Health, Risk and Society

Volumn 4, Issue 1, 2002, Pages 19-29

  Abraham, John ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Drug risk assessment; FDA; Institute of medicine; Permissive principle; Precautionary principle; Triazolam (Halcion)

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; PLACEBO; TEMAZEPAM; TRIAZOLAM;

AMNESIA; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG APPROVAL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HOSTILITY; HUMAN; INSOMNIA; MEDICAL ASSESSMENT; MEDICAL EXPERT; MEDICAL INFORMATION; PATIENT CARE; POLITICS; PSYCHOPHARMACOLOGY; PSYCHOSIS; PUBLIC HEALTH; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEIZURE; SLEEP TIME; SOCIAL ASPECT;

EID: 0036190903     PISSN: 13698575     EISSN: None     Source Type: Journal    
DOI: 10.1080/13698570210292     Document Type: Article

References (25)

1. Scientific standards and institutional interests: Carcinogenic risk assessment of benoxaprofen in the UK and US
2. FDA advisers find no major Halcion danger
3. Psychotropic drugs
4. Standards, science and the politics of chemical risk
5. Evaluation of long-term triazolam use in an ambulatory veterans administration medical center population
6. Innovation and regulation in human implant technologies: Developing comparative approaches
7. Joint hearings before the Subcommittee on Health of the Committee on Labour and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the US Senate Committee on the Judiciary
8. Boundary-work and the demarcation of science from non-science: Strains and interests in professional ideologies of scientists
9. Citizen Science: A Study of People
10. Review of adverse event data in Upjohn sponsored clinical studies of Halcion
11. Technology assessment and the sociopolitics of health technologies
12. The risk assessment/risk management boundary: Myth-making and its implications in the UK
13. Health and social characteristics of long-term psychotropic drug takers